SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it will report its unaudited financial results for the third quarter ended September 30, 2008 on Wednesday, November 5, 2008, after the U.S. financial markets close. ACADIA's management will host a conference call and webcast on Wednesday, November 5, 2008, at 5:00 p.m. Eastern Time to discuss ACADIA’s financial results and development programs.
